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A variety of names has been used in the literature for the
subunits of cytoplasmic dynein complexes. Thus, there is
a strong need for a more deﬁnitive consensus statement
on nomenclature. This is especially important for mam-
malian cytoplasmic dyneins, many subunits of which are
encoded by multiple genes. We propose names for the
mammalian cytoplasmic dynein subunit genes and pro-
teins that reﬂect the phylogenetic relationships of the
genes and the published studies clarifying the functions
of the polypeptides. This nomenclature recognizes the
two distinct cytoplasmic dynein complexes and has the
ﬂexibility to accommodate the discovery of new subunits
and isoforms.
 
Cytoplasmic dynein is the major microtubule minus end–directed
motor protein of the cell; it is involved in many essential cellu-
lar processes such as membrane trafficking and mitosis. The
cytoplasmic dynein complex is resolved on SDS–polyacrylamide
gels into subunit polypeptides of 
 
 
 
530 (dynein heavy chains),
 
 
 
74 (intermediate chains), 
 
 
 
53–59 (light intermediate chains),
and 
 
 
 
10–14 kD (light chains). Since mammalian cytoplasmic
dynein was first identified and characterized (Paschal et al.,
1987), further understanding of the subunit complexity of cyto-
plasmic dyneins has emerged (for review see Vallee et al.,
2004; Pfister et al., 2005). Only a single heavy chain gene has
been identified for the initially described form of cytoplasmic
dynein, but two intermediate chain and two light intermediate
chain genes have been found (Mikami et al., 1993; Zhang et al.,
1993; Gill et al., 1994; Hughes et al., 1995; Vaughan and
Vallee, 1995). Three light chain families have been identified,
which appear to be shared among some, but not all, cytoplasmic
and axonemal dynein complexes (King et al., 1996a,b, 1998;
Bowman et al., 1999; Wilson et al., 2001). Also, it is now
known that there are two distinct cytoplasmic dynein com-
plexes: the originally characterized complex with six subunits
and a second distinct complex with two subunits that have been
identified to date—a unique heavy chain and a unique light in-
termediate chain (Gibbons et al., 1994; Tanaka et al., 1995;
Vaughan et al., 1996; Grissom et al., 2002; Mikami et al.,
2002). Information about the 13 cytoplasmic dynein polypep-
tides has come from various sources, and individual gene and
protein names have not been coordinated in a systematic man-
ner. This article introduces a nomenclature that has been up-
dated from Vaughan et al. (1996) for use with both mouse and
human genes and suggests common names for the two cyto-
plasmic dynein complexes and their diverse subunits.
Table I shows the recommended nomenclature for mam-
malian cytoplasmic dynein genes and proteins. Although
based upon the earlier terminology that was used for dynein
genes by the human and mouse genome projects, this revised
nomenclature is modified to better reflect the phylogenetic re-
lationships of the dynein genes and the published studies clar-
ifying the functions of dynein subunits. This recommended
nomenclature has been endorsed by the Human Genome Or-
ganization Gene Nomenclature Committee (HGNC) and the
International Committee on Standardized Nomenclature for
Mice. Moreover, it conforms to the guidelines of the Interna-
tional Union of Pure and Applied Chemistry (IUPAC)-Inter-
national Union of Biochemistry and Molecular Biology Joint
Commission on Biochemical Nomenclature.
The most obvious nomenclature change is that two cyto-
plasmic dynein complexes are now recognized: cytoplasmic
dynein 1 and 2. Thus, the designations of their subunits start
with DYNC1 and DYNC2, respectively. We retain the conven-
tion of grouping the subunits of these complexes into polypeptide
families of similarly sized proteins: heavy (H), intermediate (I),
light intermediate (LI), and light (L) chains. The cytoplasmic
dynein 1 complex has three distinct light chain families, and to
systematize the light chain nomenclature, additional letters are
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used to distinguish the three families: Tctex1 (T), Roadblock
(RB), and LC8 (L). These light chains only have DYN as their
initial designation because of the abundant evidence that light
chains are shared with several axonemal dyneins (King, 2002).
Individual members of all the gene families are assigned num-
bers as before. We also retain the practice of designating the al-
ternatively spliced isoforms of the intermediate chain gene
products with letters, which is in accordance with IUPAC stan-
dards (Vaughan et al., 1996). As appropriate, letters can also be
used to distinguish alternatively spliced isoforms of members
of other gene families. We use standard human and mouse gene
formatting: italicized uppercase letters for human gene names
(for example, 
 
DYNC1H1
 
) and italicized initial uppercase fol-
lowed by lowercase letters for mice (
 
Dync1h1
 
). For the formal
names of proteins of both species, the same names in nonitali-
cized uppercase letters (DYNC1H1) are used.
Although it is recommended that the subunits be referred
to by using their formal names in publications, the rich history
of common names and the superficial similarities of some of
the formal names are recognized. Thus, it is anticipated that a
dynein polypeptide subunit will be identified at first mention
with its formal name followed by a common name in parenthe-
ses, with subsequent mentions to the common name only: for
example, DYNC1I2 (cytoplasmic dynein 1 intermediate chain
2). Also, a hyphen might be used on subsequent mentions to
minimize a potential confusion between the letter I and number
1 in some fonts (for example, DYNC1-I2). However, it is
highly recommended that the light chains in the LC8 and Road-
block families not be referred to by the aliases dynein light
chain 1, 2, 2A, and 2B, as these names are a source of consider-
able confusion. We suggest that portions of this nomenclature
system be adapted for cytoplasmic dyneins of other species as
appropriate. In the future, this nomenclature scheme may also
be readily adapted to incorporate additional cytoplasmic dy-
nein components (should they be identified) as well as the
genes and proteins of axonemal dyneins (Pazour et al., 2005).
Other researchers supporting the use of this nomenclature
for the cytoplasmic dynein subunits include Victoria Allan,
Linda Amos, David Asai, Peter Baas, Elisar Barbar, Stan Bur-
gess, John Cooper, Steven Gross, Majid Hafezparast, Leah
Haimo, Nobutaka Hirokawa, Peter Hook, Holger Hummerich,
Ritsu Kamiya, Stephen J. King, Michael Koonce, Bo Liu,
David Mitchell, Kazuhiro Oiwa, Gregory Pazour, David Pell-
man, Stephen Pilder, Samara Reck-Peterson, Vladimir Rodi-
 
Table I. 
 
Nomenclature of the mammalian cytoplasmic dynein subunits
Gene symbols
Revised
protein
symbols Common protein names
Human Mouse Human 
and
mouse Human and mouse Revised Former Revised Former
Cytoplasmic dynein 1 complex
 
DYNC1H1 DNCH1 Dync1h1 Dnchc1
 
DYNC1H1 Cytoplasmic dynein 1 heavy chain, 
conventional cytoplasmic dynein 
heavy chain, DHC1a, dynein 1, 
dynein heavy chain 1, MAP1C
 
DYNC1I1 DNCI1 Dync1i1 Dncic1
 
DYNC1I1 Cytoplasmic dynein 1 intermediate 
chain 1, IC-1, IC74-1, IC70
 
DYNC1I2 DNCI2 Dync1i2 Dncic2
 
DYNC1I2 Cytoplasmic dynein 1 intermediate 
chain 2, IC-2, IC74-2
 
DYNC1LI1 DNCLI1 Dync1li1 Dnclic1
 
DYNC1LI1 Cytoplasmic dynein 1 light 
intermediate chain 1, LIC1
 
DYNC1LI2 DNCLI2 Dync1li2 Dnclic2
 
DYNC1LI2 Cytoplasmic dynein 1 light 
intermediate chain 2, LIC2
 
DYNLT1 TCTEL1 Dynlt1 Tctex1
 
DYNLT1 Dynein Tctex1 light chain 1, Tctex1
 
DYNLT3 TCTE1L Dynlt3 Tcte1l
 
DYNLT3 Dynein Tctex1 light chain 3, rp3
 
DYNLRB1 DNCL2A Dynlrb1 Dnclc2a
 
DYNLRB1 Dynein Roadblock light chain 1, RobI1
 
DYNLRB2 DNCL2B Dynlrb2 Dnclc2b
 
DYNLRB2 Dynein Roadblock light chain 2, RobI2
 
DYNLL1 DNCL1 Dynll1 Dnclc1
 
DYNLL1 Dynein LC8 light chain 1 
 
DYNLL2 DNCL2 Dynll2 Dlc2
 
DYNLL2 Dynein LC8 light chain 2
 
Cytoplasmic dynein 2 complex
 
DYNC2H1 DNCH2 Dync2h1 Dnchc2
 
DYNC2H1 Cytoplasmic dynein 2 heavy chain, 
IFT
 
1
 
 dynein heavy chain, DHC1b, 
dynein heavy chain 2, DHC2
 
DYNC2LI1
 
n/a
 
2
 
Dync2li1
 
n/a
 
2
 
DYNC2LI1 Cytoplasmic dynein 2 light 
intermediate chain 1, D2LIC, LIC3
 
13 well-established cytoplasmic dynein components are currently identified; other components may exist. The former mouse and human gene nomenclatures are shown
along side the revised nomenclature for both species. Also shown are the suggested common protein names followed by some of the alternative names that are currently
in use. In accordance with the human and mouse nomenclature rules, all gene symbols are in italics, mice genes have an uppercase first letter and the rest are lower
case, and human genes have all uppercase letters. All protein symbols are in uppercase normal fonts. The designation cytoplasmic dynein Tctex1 light chain 2 is not
used to avoid confusion with the gene currently known as 
 
TCTEX2
 
 (human) and 
 
Tctex2
 
 (mouse), which is an axonemal dynein subunit.
 
1
 
IFT, intraflagellar transport.
 
2
 
n/a, not available. 
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